INS and Alzheimer disease: In the next years, the results of the ongoing larger clinical trials will provide further information about how metabolic status of AD patients interfere on treatment success and also the potential of anti-diabetic therapies in dementia, specially, insulin intranasal use as a possible AD therapy (Femminella et al., 2017).